advisorsecurities master

STTKShattuck Labs, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
22161
Ticker
STTK
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-10-09
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
STTK

Detail

Enriched 2026-08-14 20:47

Market cap
$751,720,764.97
Shares outstanding (class)
76,680,517
Shares outstanding (weighted)
100,363,253
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
40
Location
AUSTIN, TX
Description

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data